DNTH · Dianthus Therapeutics, Inc. /DE/ · Documents
$77.16
+2.62 (+3.51%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 4, 2026
The latest filing states the doubt was alleviated.
“In accordance with Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying unaudited condensed consolidated financial statements were issued (the "issuance date") As of the issuance date, the Company expects that its existing cash, cash equivalents and investments on hand will be sufficient to fund its obligations as they become due for at least twelve months beyond the issuance date.”View the 10-Q filed Aug 4, 2026
Market Cap
$4.17B
Shares
55.93M
Volume · Oct 20
208.13K
Avg daily vol (3M)
806.57K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| 10-Q | — | 2026-08-04 | 2026-06-30 | |
| 8-K | — | 2026-08-04 | — | |
| 8-K | — | 2026-06-12 | — | |
| Investor Event Transcript | — | 2026-06-09 | 2026-06-30 | |
| 8-K | — | 2026-05-22 | 2026-05-21 | |
| 10-Q | — | 2026-05-05 | 2026-03-31 | |
| 8-K | — | 2026-05-05 | — | |
| DEF 14A | — | 2026-04-09 | 2026-05-21 | |
| 8-K | — | 2026-03-26 | — | |
| 8-K | — | 2026-03-12 | 2026-03-10 | |
| 8-K | — | 2026-03-09 | — | |
| 10-K | — | 2026-03-09 | 2025-12-31 | |
| 8-K | — | 2026-01-12 | — | |
| 10-Q | — | 2025-11-05 | 2025-09-30 | |
| 8-K | — | 2025-11-05 | — | |
| 8-K | — | 2025-11-03 | — | |
| 8-K | — | 2025-10-16 | — | |
| 8-K | — | 2025-09-11 | 2025-09-09 | |
| 8-K | — | 2025-09-08 | — | |
| 10-Q | — | 2025-08-07 | 2025-06-30 | |
| 8-K | — | 2025-08-07 | — | |
| 8-K | — | 2025-05-22 | — | |
| 10-Q | — | 2025-05-12 | 2025-03-31 | |
| 8-K | — | 2025-05-12 | — | |
| DEF 14A | — | 2025-04-10 | 2025-05-22 | |
| 10-K | — | 2025-03-11 | 2024-12-31 | |
| 8-K | — | 2025-03-11 | — | |
| 8-K | — | 2025-03-05 | 2025-03-04 | |
| 8-K | — | 2024-12-12 | — | |
| 10-Q | — | 2024-11-07 | 2024-09-30 | |
| 8-K | — | 2024-11-07 | — | |
| 8-K | — | 2024-09-16 | — | |
| 8-K | — | 2024-08-08 | — | |
| 10-Q | — | 2024-08-08 | 2024-06-30 | |
| 8-K | — | 2024-06-06 | — | |
| 8-K | — | 2024-05-28 | 2024-05-23 | |
| 8-K | — | 2024-05-09 | — | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| DEF 14A | — | 2024-04-11 | 2024-05-23 | |
| 10-K | — | 2024-03-21 | 2023-12-31 | |
| 8-K | — | 2024-03-21 | — | |
| 8-K | — | 2024-01-22 | — | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2023-12-21 | — | |
| 8-K | — | 2023-11-09 | — | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-10-25 | 2023-10-19 | |
| 8-K/A | — | 2023-09-21 | 2023-09-11 | |
| 8-K | — | 2023-09-12 | 2023-09-11 |
Showing 1–50 of 111 filings
Key facts
CIK
1690585
CUSIP
252828108
13F (30d)
12 filings
12 filers
Visit website
Investor relations